长春中医药大学学报2024,Vol.40Issue(8) :859-863.DOI:10.13463/j.cnki.cczyy.2024.08.009

利用受体配体亲和技术筛选黄芩中血管紧张素转换酶2和二肽基肽酶4抑制剂

Study on screening angiotensin converting enzyme 2 and dipeptidyl peptidase 4 inhibitors in baical skullcap root by receptor-ligand affinity technique

康健斌 张语迟
长春中医药大学学报2024,Vol.40Issue(8) :859-863.DOI:10.13463/j.cnki.cczyy.2024.08.009

利用受体配体亲和技术筛选黄芩中血管紧张素转换酶2和二肽基肽酶4抑制剂

Study on screening angiotensin converting enzyme 2 and dipeptidyl peptidase 4 inhibitors in baical skullcap root by receptor-ligand affinity technique

康健斌 1张语迟2
扫码查看

作者信息

  • 1. 长春市中医院药剂科,长春 130052
  • 2. 长春师范大学天然药物分离纯化及活性筛选技术国家地方联合工程实验室,长春 130032
  • 折叠

摘要

目的 筛选中药黄芩中血管紧张素转换酶2(ACE2)和二肽基肽酶4(DPP-4)抑制剂.方法 以ACE2和DPP-4作为靶蛋白,利用受体配体亲和超滤和液质联用技术,对黄芩中与ACE2和DPP-4亲和的化合物进行筛选和分析,以筛选具有同时抑制ACE2和DPP-4的化合物.结果 从黄芩中筛选出了 5,7,2',6'-4羟基黄酮、5,7,2',5'-4羟基.8,6'-二甲氧基黄酮、白杨素-7-O-葡萄糖醛酸苷、黄芩素-6-O-葡萄糖醛酸苷、千层纸素A-7-O-葡萄糖醛酸苷、汉黄芩苷、白杨素、千层纸素A,可以同时亲和抑制ACE2和DPP-4,具有潜在的抗新型冠状病毒的作用.结论 从黄芩中筛选出与新型冠状病毒肺炎有关的靶蛋白抑制剂,具备潜在开发价值.

Abstract

Objective To screen the inhibitors of angiotensin converting enzyme 2(ACE2)and dipeptidyl peptidase 4(DPP-4)from baical skullcap root.Methods ACE2 and DPP4 were used as the target proteins,the compounds in baical skullcap root that were compatible with ACE2 and DPP4 were screened and analyzed by receptor-ligand affinity ultrafiltration and liquid chromatography-mass spectrometry,in order to screen compounds that could simultaneously inhibit ACE2 and DPP-4.Results 5,7,2',6'-4 hydroxyflavone,5,7,2',5'-4 hydroxy-8,6'-dimethoxyflavone,chrysin-7-O-glucuronide,baicalein-6-O-glucuronide,oroxylin A-7-O-glucuronide,wogonoside,chrysin,oroxylin A were screened from baical skullcap root,and their affinity and inhibition towards ACE2 and DPP-4 coexisted,and they had potential anti novel coronavirus effect.Conclusion The target protein inhibitors related to novel coronavirus pneumonia screened from baical skullcap root have potential development value.

关键词

受体配体亲和/血管紧张素转换酶2/二肽基肽酶4/抑制剂

Key words

receptor ligand affinity/angiotensin converting enzyme 2/dipeptidyl peptidase 4/inhibitor

引用本文复制引用

基金项目

中央本级重大增减支项目(2060302)

出版年

2024
长春中医药大学学报
长春中医药大学

长春中医药大学学报

CSTPCD
影响因子:0.916
ISSN:1007-4813
参考文献量3
段落导航相关论文